04275nam 22007095 450 991086657670332120260902101513.0978981194484010.1007/978-981-19-4484-0(CKB)32317109200041(MiAaPQ)EBC31496581(Au-PeEL)EBL31496581(DE-He213)978-981-19-4484-0(OCoLC)1443942412(EXLCZ)993231710920004120240618d2024 u| 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierDrug Targets for Plasmodium Falciparum: Historic to Future Perspectives /by Mohammed Tarique1st ed. 2024.Singapore :Springer Nature Singapore :Imprint: Springer,2024.1 online resource (205 pages)Biomedical and Life Sciences Series9789811944833 Chapter 1. Introduction: An overview of Malaria and Plasmodium -- Chapter 2. Pathogenesis of Plasmodium falciparum -- Chapter 3. Antimalarial Drugs and drug resistance -- Chapter 4. Metabolic pathways of Enzymes: Therapeutic targets and prospects for Innovative antimalarial drugs -- Chapter 5. Targeting apicoplasts in Plasmodium falciparum, origin and pathways -- Chapter 6. Proteases and protein kinases as potential drug target -- Chapter 7. Plasmodium falciparum: Transporter and Drug Target -- Chapter 8. Enzymes of isoprenoid biosynthesis and control of malarial parasite plasmodium falciparum -- Chapter 9.Ubiquitin-Proteasome system as a potential drug target for Malaria -- Chapter 10.Food Vacuole as a Drug Target.This book offers a comprehensive exploration of malaria, a life-threatening disease affecting millions globally, with a focus on the parasitic organisms of the genus Plasmodium that cause it. It discusses the challenges posed by the disease, especially in economically developing regions, and delves into the biology and pathophysiology of the Plasmodium species, including their genetic flexibility and resistance to treatments. Special attention is given to P. falciparum, the most dangerous of these parasites, detailing its complex life cycle, interaction with human hosts, and the severe clinical manifestations it can induce. The book further explores the global health concern of antimalarial drug resistance, highlighting the WHO's efforts in combating the disease and the necessity for novel treatments. Innovative research directions, such as targeting the unique organelles of Plasmodium like the apicoplast and employing proteasome inhibitors, are thoroughly examined as potential strategies in the development of new antimalarial drugs. Additionally, it addresses the critical role of the hemoglobin digestion process in the parasite's lifecycle, presenting it as a promising target for therapeutic intervention. This work is an essential resource for researchers, clinicians, and policymakers involved in malaria control and drug development, providing insights into the current challenges and future directions in the fight against this endemic disease.ParasitologyProteinsDiseasesCauses and theories of causationPharmacologyParasitologyProteinsPathogenesisPharmacologyDianes farmacològiquesthubParasitologiathubFarmacologiathubProteïnesthubLlibres electrònicsthubParasitology.Proteins.DiseasesCauses and theories of causation.Pharmacology.Parasitology.Proteins.Pathogenesis.Pharmacology.Dianes farmacològiquesParasitologiaFarmacologiaProteïnes579.4Tarique Mohammed1916930MiAaPQMiAaPQMiAaPQ9910866576703321Drug Targets for Plasmodium Falciparum: Historic to Future Perspectives4660230UNINA